Semler Scientific sued for alleged securities fraud.

Bragar Eagel & Squire, a law firm, has filed a class action lawsuit against Semler Scientific, Inc. (NASDAQ:SMLR) on behalf of investors who purchased or acquired the company's securities between March 10, 2021 and April 15, 2025. The lawsuit alleges that Semler made false or misleading statements during this period. Investors who suffered losses are encouraged to contact Brandon Walker at (212) 355-4648 for legal advice.

A class action lawsuit has been filed against Semler Scientific, Inc. (NASDAQ: SMLR) by Bragar Eagel & Squire, P.C. on behalf of investors who purchased or acquired the company's securities between March 10, 2021 and April 15, 2025. The lawsuit alleges that Semler made materially false and misleading statements during this period, resulting in financial losses for investors.

The lawsuit, filed in the United States District Court, Northern District of California, claims that Semler Scientific did not disclose a material investigation by the United States Department of Justice (DOJ) into violations of the False Claims Act. Instead, the company discussed possible violations of the False Claims Act in hypothetical terms, which was misleading to investors. When the true details entered the market, investors suffered damages.

Investors who believe they may have been affected by these alleged false statements are encouraged to contact Brandon Walker or Marion Passmore of Bragar Eagel & Squire, P.C. at (212) 355-4648 or by email at investigations@bespc.com. There is no cost or obligation to contact the firm. The deadline to apply to the Court to be appointed as lead plaintiff is October 28, 2025.

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.